ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function.

Neurobiology of Aging
Martina de MajoChristopher E Shaw

Abstract

Mutations in TANK binding kinase 1 (TBK1) have been linked to amyotrophic lateral sclerosis. Some TBK1 variants are nonsense and are predicted to cause disease through haploinsufficiency; however, many other mutations are missense with unknown functional effects. We exome sequenced 699 familial amyotrophic lateral sclerosis patients and identified 16 TBK1 novel or extremely rare protein-changing variants. We characterized a subset of these: p.G217R, p.R357X, and p.C471Y. Here, we show that the p.R357X and p.G217R both abolish the ability of TBK1 to phosphorylate 2 of its kinase targets, IRF3 and optineurin, and to undergo phosphorylation. They both inhibit binding to optineurin and the p.G217R, within the TBK1 kinase domain, reduces homodimerization, essential for TBK1 activation and function. Finally, we show that the proportion of TBK1 that is active (phosphorylated) is reduced in 5 lymphoblastoid cell lines derived from patients harboring heterozygous missense or in-frame deletion TBK1 mutations. We conclude that missense mutations in functional domains of TBK1 impair the binding and phosphorylation of its normal targets, implicating a common loss of function mechanism, analogous to truncation mutations.

Citations

Jun 28, 2019·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Veronica Hirsch-ReinshagenIan R Mackenzie
Mar 24, 2020·Nature Reviews. Neurology·Francesco PanzaBruno P Imbimbo
Mar 13, 2019·Cells·Esther Hui Na Tan, Bor Luen Tang
May 24, 2019·Journal of Neurology·Caroline V Greaves, Jonathan D Rohrer
Mar 3, 2020·Frontiers in Neuroscience·Yevgeniya A AbramzonRuth Chia
Dec 1, 2019·Molecular Brain·Bilal R MalikOwen M Peters
Jul 16, 2020·Brain : a Journal of Neurology·Miguel Tábuas-PereiraRita Guerreiro
Aug 18, 2020·Molecular Neurodegeneration·Terry R Suk, Maxime W C Rousseaux
Aug 1, 2020·Frontiers in Neuroscience·Ramya RanganathanJanine Kirby
Oct 11, 2020·Experimental Neurology·Kirsten SieverdingJochen H Weishaupt
Jan 18, 2021·Matrix Biology : Journal of the International Society for Matrix Biology·Lina Herhaus
Mar 17, 2021·Expert Opinion on Therapeutic Patents·Douglas W Thomson, Giovanna Bergamini
Sep 16, 2020·Neuron·Garam KimAaron D Gitler
Apr 2, 2021·Journal of Experimental Pharmacology·Marcello GiuntaAlberto Benussi
Apr 16, 2021·Genome Medicine·Federica PerroneChristine Van Broeckhoven
May 1, 2021·International Journal of Molecular Sciences·Emma KällstigBernard L Schneider
Jun 5, 2020·Neuron·Keith Mayl, Jemeen Sreedharan
Jun 9, 2021·Proceedings of the National Academy of Sciences of the United States of America·Olivia HardingErika L F Holzbaur
Jun 11, 2021·International Journal of Biological Macromolecules·Manzar AlamMd Imtaiyaz Hassan
Nov 30, 2021·Acta Neurologica Scandinavica·Faheem ArshadSuvarna Alladi

❮ Previous
Next ❯

Methods Mentioned

BETA
Exome Sequencing
transfection
immunoprecipitation
PCR
Co-IP
pull down

Software Mentioned

ALSdb
King
custom
ALS browser
ImageJ
bcftools
GeneSplicer
SAMtools
GraphPad Prism
vcftools

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
Aritoshi IidaShiro Ikegawa
Transactions of the American Neurological Association
S A HouffJ R Taylor
La Presse médicale
M BONDUELLEC FAVERET
© 2022 Meta ULC. All rights reserved